Drug-drug interaction software in clinical practice: a systematic review.
about
Drug interaction databases in medical literature: transparency of ownership, funding, classification algorithms, level of documentation, and staff qualifications. A systematic review.Comparison of three commercial knowledge bases for detection of drug-drug interactions in clinical decision support.Cardiovascular Function in Intensive Care Medicine or Homo Mensura EstToward standardized reporting of drug interactions: the READI checklist for anecdotal reports.Psychocardiology in the elderly.The prevalence and preventability of potentially relevant drug-drug interactions in patients admitted for cardiovascular diseases: A cross-sectional study.Potential drug-drug interactions in medical intensive care unit of a tertiary care hospital in Pakistan.A comparison of five common drug-drug interaction software programs regarding accuracy and comprehensiveness.Medication adherence, medical record accuracy, and medication exposure in real-world patients using comprehensive medication monitoring.Frequency, characteristics and risk factors of QT interval prolonging drugs and drug-drug interactions in cancer patients: a multicenter study.Potential drug-drug interactions and their risk factors in pediatric patients admitted to the emergency department of a tertiary care hospital in Mexico.Prevalence of QT interval prolonging drug-drug interactions (QT-DDIs) in psychiatry wards of tertiary care hospitals in Pakistan: a multicenter cross-sectional study.The relativity of age or geriatric medicine at the crossroads.Comparative analysis of three drug-drug interaction screening systems against probable clinically relevant drug-drug interactions: a prospective cohort study.Potential Drug-Drug Interactions in a Cohort of Elderly, Polymedicated Primary Care Patients on Antithrombotic Treatment.
P2860
Q30488323-D5A27436-FCEE-45F6-A9B8-7C25AFCECEF4Q36322239-19E95BA2-6D3C-4E90-A72B-B656AFBEAF81Q36805932-8EB1119D-3522-4541-A4B6-550E26F5A58EQ38505127-5854FB85-F806-49BD-AE72-E90248D5A8C1Q39023153-904BAC48-EC9A-4154-BEC8-657473A9C7ACQ40067944-FA1C7BED-254F-4F73-8F3A-E3057DBD30E4Q40672604-EF7F390E-2F62-4D70-988E-4077CD7E487DQ41605624-CC48F0F0-818F-4770-888C-E0D3149CFCBBQ42366237-9BCDC786-5853-4C77-B5DD-AAD942DC1F05Q47146166-DA4B1018-3217-42D1-93A7-4FC601A8FED6Q47205589-BF6F855D-3EB6-478B-AC38-34E4465BC785Q47643184-D08F7BB7-263C-4B2D-B6C2-FF9F98E649BBQ53738119-0B235B7C-F626-4A9C-9762-3E422ECA3E0FQ54261327-86DA1C16-9E32-4C8E-9A0B-BADAFE5F250BQ55363294-8EF39F82-E8A2-404F-AA73-599EC0D094D1
P2860
Drug-drug interaction software in clinical practice: a systematic review.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Drug-drug interaction software in clinical practice: a systematic review.
@en
type
label
Drug-drug interaction software in clinical practice: a systematic review.
@en
prefLabel
Drug-drug interaction software in clinical practice: a systematic review.
@en
P2093
P2860
P1476
Drug-drug interaction software in clinical practice: a systematic review.
@en
P2093
Ales Mrhar
Tina Roblek
Tomaz Vaupotic
P2860
P2888
P304
P356
10.1007/S00228-014-1786-7
P577
2014-12-23T00:00:00Z
P6179
1027283882